Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug  Effectiveness Review Project
Kylie Thaler1, Divya V Chandiramani2, Richard A Hansen2, Gerald Gartlehner11Department for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria; 2UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAObjec...
Enregistré dans:
Auteurs principaux: | Kylie Thaler, Divya V Chandiramani, Richard A Hansen, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/811a2bc9f0484d3abe7e374918ad85a6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
par: Mahamid M, et autres
Publié: (2011) -
Safety of etanercept in elderly subjects with rheumatoid arthritis
par: Alfredomaria Lurati, et autres
Publié: (2009) -
Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009) -
An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
par: Bullement A, et autres
Publié: (2021) -
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
par: Joseph R Lutt
Publié: (2009)